Enanta Pharmaceuticals
ENTA
#8727
Rank
A$0.19 B
Marketcap
$8.92
Share price
2.42%
Change (1 day)
-56.05%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Cash on Hand

Cash on Hand as of December 2024 : A$0.33 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company has A$0.33 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Enanta Pharmaceuticals - Cash on Hand chart (from 2011 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-09-30A$0.35 B-37.67%
2023-09-30A$0.57 B50.38%
2022-09-30A$0.38 B12.6%
2021-09-30A$0.33 B-37.21%
2020-09-30A$0.54 B9.16%
2019-09-30A$0.49 B16.03%
2018-09-30A$0.42 B49.77%
2017-09-30A$0.28 B3.61%
2016-09-30A$0.27 B32.84%
2015-09-30A$0.20 B99.11%
2014-09-30A$0.10 B-4.56%
2013-09-30A$0.10 B158.73%
2012-09-30A$42.16 M76.5%
2011-09-30A$23.89 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$8.66 B 2,463.56%๐Ÿ‡บ๐Ÿ‡ธ USA
A$60.50 B 17,796.91%๐Ÿ‡บ๐Ÿ‡ธ USA
A$9.54 B 2,722.41%๐Ÿ‡บ๐Ÿ‡ธ USA
A$21.35 B 6,217.29%๐Ÿ‡บ๐Ÿ‡ธ USA
A$18.38 B 5,337.24%๐Ÿ‡บ๐Ÿ‡ธ USA
A$20.83 B 6,061.31%๐Ÿ‡จ๐Ÿ‡ญ Switzerland